文献速递关节外科

氨甲环酸与初次全关节置换术后假体周围感染减少相关

Tranexamic Acid Is Associated With Reduced Periprosthetic Joint Infection After Primary Total Joint Arthroplasty.
PubMed 文献 · J Arthroplasty · 2019-10-22

该研究利用机构数据库纳入2013年1月1日至2017年6月31日期间接受初次全关节置换术且随访至少1年的6340例患者,按是否术前静脉使用氨甲环酸分组,比较假体周围感染发生率。多因素回归分析显示,在调整所有混杂变量后,氨甲环酸与初次全关节置换术后假体周围感染减少相关。

要点

  • 静脉氨甲环酸与初次全关节置换术后假体周围感染减少相关。
  • 3683例(58.1%)接受氨甲环酸,2657例(41.9%)未接受。
  • 总体假体周围感染发生率为2.4%,术前贫血发生率为16%。

核心结论

  • 氨甲环酸有助于降低初次全关节置换术后假体周围感染发生率。
  • 该保护作用可能与减少失血、降低异体输血需求及输血相关免疫调节有关。

研究设计与样本

  • 利用机构数据库识别2013年1月1日至2017年6月31日期间接受初次全关节置换术、随访至少1年的6340例患者。
  • 按术前是否接受静脉氨甲环酸分为两组,所有假体周围感染患者均符合2018年国际共识会议定义。
  • 采用多因素回归分析识别与假体周围感染独立相关的变量。

主要发现

  • 3683例(58.1%)接受氨甲环酸,2657例(41.9%)未接受。
  • 总体术前贫血发生率为16%,术后输血率为1.8%,假体周围感染发生率为2.4%。
  • 双变量分析显示接受氨甲环酸的患者感染风险显著降低。
  • 调整所有混杂变量后,多因素回归分析显示氨甲环酸与初次全关节置换术后假体周围感染减少相关。

关键数值与推荐

  • 假体周围感染诊断均符合2018年国际共识会议定义。
  • 多因素回归分析用于识别与假体周围感染独立相关的变量。

临床怎么用

  • 在初次全关节置换术中可考虑静脉使用氨甲环酸以降低假体周围感染风险。
  • 氨甲环酸的保护作用可能部分通过减少失血和异体输血实现。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Previous studies have demonstrated preoperative anemia to be a strong risk factor for periprosthetic joint infection (PJI) in total joint arthroplasty (TJA). Allogeneic blood transfusion can be associated with increased risk of PJI after primary and revision TJA. Tranexamic acid (TXA) is known to reduce blood loss and the need for allogeneic blood transfusion after TJA. The hypothesis of this study is that administration of intravenous TXA would result in a reduction in PJI after TJA. METHODS: An institutional database was utilized to identify 6340 patients undergoing primary TJA between January 1, 2013 and June 31, 2017 with a minimum of 1-year follow-up. Patients were divided into 2 groups based on whether they received intravenous TXA prior to TJA or not. Patients who developed PJI were identified. All PJI patients met the 2018 International Consensus Meeting definition for PJI. A multivariate regression analysis was performed to identify variables independently associated with PJI. RESULTS: Of the patients included, 3683 (58.1%) received TXA and 2657 (41.9%) did not. The overall incidence of preoperative anemia was 16%, postoperative blood transfusion 1.8%, and PJI 2.4%. Bivariate analysis showed that patients who received TXA were significantly at lower odds of infection. After adjusting for all confounding variables, multivariate regression analysis showed that TXA is associated with reduced PJI after primary TJA. CONCLUSION: TXA can help reduce the rate of PJI after primary TJA. This protective effect is likely interlinked to reduction in blood loss, lower need for allogeneic blood transfusion, and issues related to immunomodulation associated with blood transfusion.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Yazdi H, Klement MR, Hammad M, et al. Tranexamic Acid Is Associated With Reduced Periprosthetic Joint Infection After Primary Total Joint Arthroplasty. J Arthroplasty. 2019. PMID: 31722855. doi:10.1016/j.arth.2019.10.029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。